Developing a new generation of Optogenetic Therapy designed to restore vision lost to inherited retinal disease

Dallas, TX
Proud to share important global regulatory updates for our lead disease-agnostic optogenetic therapy, MCO-010: Read the full PR: bit.ly/3Vs3NIv #retina #ophthalmology #Retinitispigmentosa #stargardt
3
9
46
5,437
Excited to attend #ASRS2025 in Long Beach! See you there. @asrsdocs tp://bit.ly/3TX3dSx #retinitispigmentosa #ophthalmology #retina #rp @NSTherapeutics
2
6
28
3,563
A new peer-reviewed paper has been published highlighting groundbreaking research that supports our lead asset therapy, MCO-010, and its potential to help restore vision in people living with retinal degenerative diseases. bit.ly/3IH0DgX #RP #fightblindness
1
8
36
2,408
We are proud to announce the initiation of a rolling submission of a BLA to the US FDA for our lead investigational therapy, MCO-010, for the treatment of severe vision loss due to #retinitispigmentosa #RP bit.ly/4nO7PYD #fightblindness
7
14
61
4,548
Exciting news at @NSTherapeutics! Excited to welcome #retina leaders to our new Visionary Advisory Committee. Read more: bit.ly/40jXycv#ophthalmology #genetherapy
3
5
23
1,427
@NSTherapeutics in New Orleans this week for #ASGCT2025! We are excited to present groundbreaking research on our MCO-010 - vision restoring #genetherapy for #RP and #Stargardt. Details bit.ly/45amFSr #ophthalmology #restorevision
4
6
33
2,466
Congratulations to Dr. Subrata Batabyal, or Director, Nonclinical Developement! We celebrate your accomplishments. Details: bit.ly/4jWkJ47
2
3
23
1,728
@NSTherapeutics welcomes Ashish Patel, PhD as SVP, Sales&Marketing. Full details bit.ly/3FGKfeW #genetherapy #ophthalmology #biotechnology
4
4
23
1,969
We are excited welcome Ramesh Arjunji, PhD, to the Nanoscope team. Details: bit.ly/4h8FbwX
4
4
27
1,630
Welcome Ray Kaczmarek to @NSTherapeutics .
5
4
24
3,433
Excited that Dr. Mohapatra will present today at the Vitreo-Retinal Society-India Annual Conference. If you are there, do not miss his talk! #retinitispigmentosa #clinicaltrials #retina
3
3
16
2,829
Nanoscope Therapeutics retweeted
ICYMI: At 52 weeks posttreatment, patients treated in the high dose cohort showed a mean improvement of 0.337 ± 0.0829 LogMAR in comparison to the sham-control group (P = .0209). #RetinitisPigmentosa #Ophthalmology #AAO2024 @NSTherapeutics Read more: cgtlive.com/view/nanoscope-t…
1
4
30
2,282
Welcome Sunil Gupta, MD to the Nanoscope Therapeutics Inc. Board of Directors. Dr. Gupta is a nationally recognized retinal surgeon and a successful entrepreneur who brings deep experience in all phases of drug development and medical devices. bit.ly/3YFkQrH
1
18
1,600
@NSTherapeutics leadership will be presenting at #AAO2024 later this week in Chicago. Presentations will update on MCO-010 for #RP, #Stargardts, #GA For full details: bit.ly/4f4u0of
1
6
31
2,188
Friday in Barcelona at #Euretina2024. Prof. Jordi Mones presenting topline results from our Phase 2b/3 #ClinicalTrials of MCO-010 for #Retinitispigmentosa. Join us!
4
5
33
2,559
Today at @EURETINA Congress. Don't miss our Symposium to learn more about groundbreaking optogenetic therapies for retinal disease. #retinitispigmentosa #genetherapy #euretina2024
1
4
27
1,380
Great crowd today for @NSTherapeutics CMO Dr. Samuel Barone's presentation at Ophthalmology Futures Forum in Barcelona where he talked about our optogenetic #genetherapy pipelines for #retinitispigmentosa, #stargardt and #GA #off2024 #euretina2024 #retina
3
24
1,306